September 17, 2024
TOPLINE: Having an untreated unruptured intracranial aneurysm (UIA) was associated with a 10% higher risk of mental illness than not having a UIA, especially among younger […]
September 16, 2024
Researchers have developed a blood test for amyotrophic lateral sclerosis (ALS) that could lead to more rapid and accurate diagnosis when used alongside standard clinical evaluations. […]
September 13, 2024
The US Food and Drug Administration (FDA) has approved a subcutaneous formulation of the anti-CD20 antibody ocrelizumab (Ocrevus Zunovo, Genentech) for the treatment of relapsing multiple […]
September 13, 2024
TOPLINE: Amyloid pathology typical of Alzheimer’s disease (AD) is 50% lower in patients with multiple sclerosis (MS) than in those without the condition, an analysis of […]
September 10, 2024
TOPLINE: Dementia in Parkinson’s disease (PD) may occur less frequently or develop over a longer period than previously thought, an analysis of two studies suggests. Increasing […]
September 9, 2024
Postoperative cognitive dysfunction (POCD) is a form of cognitive decline that involves a functional deterioration of activities of the nervous system, such as selective attention, vigilance, […]
September 9, 2024
TOPLINE: The likelihood of receiving a dementia diagnosis in older adults varies significantly by region across the United States, a new study suggests. Rates ranged from […]
September 9, 2024
Adding balloon angioplasty to aggressive medical management significantly lowers the risk for stroke or death in patients with symptomatic intracranial atherosclerotic stenosis (sICAS), results of a […]
September 6, 2024
A potential first-in-class therapy for migraine prevention has shown promise in a phase 2a proof-of-concept study, with a single infusion reducing migraine frequency over 4 weeks. […]